Professional Documents
Culture Documents
org/JACS Article
■ INTRODUCTION
Prostate cancer (PCa) is one of the most common cancers that
The key to our success roots in the design of a cascade
response model, which takes integrated enzyme as a specific
seriously influences the health of men. For most patients, there recognition unit and coupled luminescent molecule as a signal
reporter (Scheme 1). The specificity of an enzymatic reaction
are no obvious clinical symptoms in incipient stages, so that
between sarcosine oxidase (SOX) and sarcosine could
early screening of PCa is crucial for improving their life quality
effectively avoid interference from structurally similar bio-
and reducing mortality.1 Herein, a convenient, reliable, and
molecules. Meanwhile, sarcosine would be effectively con-
specific strategy has been successfully proposed to screen PCa
verted to the products through consuming equimolar dissolved
individuals through quantifying sarcosine levels in the clinical
oxygen (DO). The variation of DO could be immediately
urine samples. Compared to the traditional prostate-specific
distinguished by the coupled oxygen-sensitive indicators,
antigen test to identify PCa, no complex and time-consuming
thereby giving an indirect luminescent response toward
sampling process and no expensive automated equipment are
sarcosine.8,9 Unfortunately, given the poor stability of enzymes
needed hereof.2,3 Sarcosine was verified to be a clinical marker
and the self-aggregation tendency of hydrophobic luminescent
for the early stage PCa, and its levels in urine allow for simple
molecules, the heterogeneous support is essential to couple
and noninvasive early diagnosis.4,5 Generally, sarcosine is them into one entity, thus achieving convenient measurement
produced at the concentration of 1−3 × 10−6 mol·L−1 in of sarcosine in complex biological samples.
human urine under normal physiological conditions, while it Thanks to the open mesochannels and designable topology,
only increases by less than an order of magnitude during the full advantages of hierarchical mesoporous Zr-based metal−
pathological process of PCa.5,6 Additionally, the probes are
generally vulnerable to numerous interferences from possibly
coexistent biomolecules in the clinical samples.7 It is Received: June 2, 2021
consequently hard to precisely distinguish the tiny concen- Published: September 8, 2021
tration change of sarcosine, leading to the risk of false-positive/
negative diagnosis. These issues make sensitive and specific
detection of sarcosine in clinical samples challenging but of
great significance.
Scheme 1. Schematic Illustration for the Proposed Enzyme- type MOFs (HMUiO) with tailorable mesopore size. The
Promoted Cascade Sensory Modela PEO-PPO-PEO triblock copolymer was utilized as a template
to guide the growth of mesoMOFs with the aid of Hofmeister
salting-in ion, which not only enhances the solubility of organic
linkers but also bridges the precursor of MOFs and PEO-
containing surfactant.31 To regulate the mesopore size of
MOFs, a hydrophobic compound was introduced and
positioned in the micelle core of the surfactant in virtue of
their similar hydrophobicity.32,33 As expected, the mesopore
size could be systematically tuned in the range from 6.4 to 12.1
nm. The correlations of the enzyme loading capacity and
sensory properties of the obtained HMUiO with different
mesopore size were also exploited. The probe with optimized
a mesopore size was applied to specifically screen PCa patients
The enzyme immobilized in the mesoporous domain would rapidly
recognize the biomarker (as its substrate) and convert it into the through quantifying the tiny concentration change of sarcosine
corresponding products through an oxygen consumption process in the urine samples. By altering the type of encapsulated
(blue region). Thus, the decreased concentration of O2 would induce enzymes, such a concept of enzyme-assisted substrate sensing
the phosphorescent enhancement of the O2-sensitive TCPP-Pt could be facilely extended, hopefully paving the way for the
strutted in the neighboring microporous domain (pink region), rational design of a variety of other luminescent probes for the
thereby achieving the specific recognition of the biomarker. convenient quantification of various biomarkers.
Figure 1. (A) Schematic illustration for the one-pot assembly process of the hierarchical TCPP-Pt@HMUiO with tunable mesopore size through a
Hofmeister ion-mediated template strategy. (B) Nitrogen sorption isotherms and (C) their corresponding BJH pore size distribution profiles of the
TCPP-Pt@HMUiO synthesized with varied TMB/F127 feed ratios of (a) 0, (b) 4.5, (c) 9.1, (d) 18.1, (e) 27.2, and (f) 36.2. (D) The effect of
TMB content in the initial reactant mixture on the distribution of mesopore size in the final product.
15146 https://doi.org/10.1021/jacs.1c05674
J. Am. Chem. Soc. 2021, 143, 15145−15151
Journal of the American Chemical Society pubs.acs.org/JACS Article
■ CONCLUSIONS
In summary, an enzyme-assisted substrate sensing model was
proposed for the specific screening of PCa patients. Newly
developed hierarchical mesoMOFs with a continuously tunable
mesopore size between 6.4 and 12.1 nm guaranteed the
synergetic work of the encapsulated SOX and integrated
oxygen-sensitive indicator. The proposed probe could realize a
linear luminescent quantification of sarcosine in the range of
0−100 μM with a LOD of 2.1 μM. Based on the sensitivity and
specificity of the enzymatic reaction, the indirect identification
of tiny sarcosine changes in the urine samples between PCa
individuals and healthy humans was successfully realized. Such
Figure 4. Changes of the luminescent intensity of the TCPP-Pt/
hierarchical mesoMOFs are competent for the immobilization
SOX@HMUiO at 665 nm against various interfering species (0−100 of various oxidases as recognition units, thus holding great
μM) (A) without and (B) with the addition of sarcosine. Sar, promise to quantify a diversity of biomarkers for the diagnosis
of relative diseases.
■
sarcosine; Gly, glycine; Tyr, tyrosine; His, histidine; Ala, alanine; Ser,
serine; and UA, uric acid. (C) The emission intensity of TCPP-Pt/
SOX@HMUiO for three PCa patients (red columns), three healthy ASSOCIATED CONTENT
males (green columns), and three healthy females (blue columns). * Supporting Information
sı
(D) Luminescent spectra of TCPP-Pt/SOX@HMUiO from human The Supporting Information is available free of charge at
urine added with different concentrations of sarcosine.
https://pubs.acs.org/doi/10.1021/jacs.1c05674.
Experimental details, DLS profiles, XRD patterns, SEM
(Figure 4C), indicating that the probe could effectively and TEM images of the mesoMOFs with different TMB,
respond to sarcosine in the urine samples. By converting the 1
H NMR, luminescent spectra, UV−vis spectra, and
luminescent intensity of probe into the biomarker concen-
Tables S1−S4 of the mesoMOFs (PDF)
■
tration, the mean sarcosine concentration of patient samples
was determined to be around 16.9 μM, which was
approximately 8 times higher than that of a healthy human. AUTHOR INFORMATION
These results indicated that the developed probe could Corresponding Author
effectively and precisely provide a positive diagnosis of Jinlou Gu − Key Laboratory for Ultrafine Materials of
sarcosine biomarker for PCa patients. To further evaluate the Ministry of Education, School of Materials Science and
accuracy of the procedure, the recovery experiments were Engineering, East China University of Science and
carried out on the urine sample of patient 1 through the extra Technology, Shanghai 200237, China; orcid.org/0000-
addition of sarcosine.39 As shown in Figure 4D, the 0002-3190-573X; Email: jinlougu@ecust.edu.cn
luminescent intensity of TCPP-Pt/SOX@HMUiO probe
increased upon adding the urine sample of patient 1 to the Authors
sensory system, and the concentration of sarcosine was Liwei Zhao − Key Laboratory for Ultrafine Materials of
quantified to be about 21.25 μM. When extra sarcosine (30 Ministry of Education, School of Materials Science and
μM) was added, a stronger luminescent enhancement could be Engineering, East China University of Science and
observed (Figure 4D, blue line), and the calculated sarcosine Technology, Shanghai 200237, China
concentration matched well with the extra added amount of Jian Yang − Key Laboratory for Ultrafine Materials of
sarcosine. The high recoveries ranging from 98.91% to Ministry of Education, School of Materials Science and
101.94% evidence the accuracy of the probe for the detection Engineering, East China University of Science and
of sarcosine in the urine sample (Table S3), further prefiguring Technology, Shanghai 200237, China; orcid.org/0000-
its great practical prospect in screening of PCa patients from a 0002-4451-0497
large group of asymptomatic healthy or diseased population. Ming Gong − Key Laboratory for Ultrafine Materials of
Based on such a cascade sensory model, other metabolic Ministry of Education, School of Materials Science and
biomarkers could be conveniently checked as long as the Engineering, East China University of Science and
immobilized enzymes were altered. Taking the representative Technology, Shanghai 200237, China
enzyme of glucose oxidase (GOX) as an example, the loading Ke Li − Key Laboratory for Ultrafine Materials of Ministry of
capacity of GOX in the TCPP-Pt@HMUiO probe with Education, School of Materials Science and Engineering, East
mesopore size of 12.1 nm could reach high up to China University of Science and Technology, Shanghai
approximately 214 mg·g−1 (Figure S38). The elaborated 200237, China
TCPP-Pt/GOX@HMUiO presented a good linear response Complete contact information is available at:
toward the detection of glucose (Figures S39 and S40), and https://pubs.acs.org/10.1021/jacs.1c05674
the LOD value was determined to be about 2.7 μM. Further
extension of such sensory system could focus on the Notes
immobilization of larger-size enzymes such as urate oxidase The authors declare no competing financial interest.
15149 https://doi.org/10.1021/jacs.1c05674
J. Am. Chem. Soc. 2021, 143, 15145−15151
Journal of the American Chemical Society
■
pubs.acs.org/JACS Article
■ REFERENCES
(1) Berger, M. F.; Lawrence, M. S.; Demichelis, F.; Drier, Y.;
Powered Porous Micromotors Built from a Hierarchical Micro- and
Mesoporous UiO-Type Metal-Organic Framework. J. Am. Chem. Soc.
2020, 142, 20962−20967.
(16) Chen, Y.; Li, P.; Zhou, J.; Buru, C. T.; Đorđević, L.; Li, P.;
Cibulskis, K.; Sivachenko, A. Y.; Sboner, A.; Esgueva, R.; Pflueger, D.;
Sougnez, C.; Onofrio, R.; Carter, S. L.; Park, K.; Habegger, L.; Zhang, X.; Cetin, M. M.; Stoddart, J. F.; Stupp, S. I.; Wasielewski, M.
Ambrogio, L.; Fennell, T.; Parkin, M.; Saksena, G.; Voet, D.; Ramos, R.; Farha, O. K. Integration of Enzymes and Photosensitizers in a
A. H.; Pugh, T. J.; Wilkinson, J.; Fisher, S.; Winckler, W.; Mahan, S.; Hierarchical Mesoporous Metal-Organic Framework for Light-Driven
Ardlie, K.; Baldwin, J.; Simons, J. W.; Kitabayashi, N.; MacDonald, T. CO2 Reduction. J. Am. Chem. Soc. 2020, 142, 1768−1773.
Y.; Kantoff, P. W.; Chin, L.; Gabriel, S. B.; Gerstein, M. B.; Golub, T. (17) Wang, K.; Feng, L.; Yan, T.; Wu, S.; Joseph, E. A.; Zhou, H.
R.; Meyerson, M.; Tewari, A.; Lander, E. S.; Getz, G.; Rubin, M. A.; Rapid Generation of Hierarchically Porous Metal-Organic Frame-
Garraway, L. A. The Genomic Complexity of Primary Human works through Laser Photolysis. Angew. Chem., Int. Ed. 2020, 59,
Prostate Cancer. Nature 2011, 470, 214−220. 11349−11354.
(2) Lilja, H.; Ulmert, D.; Vickers, A. J. Prostate-Specific Antigen and (18) Lu, J.; Wu, J.-K.; Jiang, Y.; Tan, P.; Zhang, L.; Lei, Y.; Liu, X.-
Prostate Cancer: Prediction, Detection and Monitoring. Nat. Rev. Q.; Sun, L.-B. Fabrication of Microporous Metal-Organic Frameworks
Cancer 2008, 8, 268−278. in Uninterrupted Mesoporous Tunnels: Hierarchical Structure for
(3) Li, H.; Huang, Y.; Hou, G.; Xiao, A.; Chen, P.; Liang, He.; Efficient Trypsin Immobilization and Stabilization. Angew. Chem., Int.
Huang, Y.; Zhao, X.; Liang, L.; Feng, X.; Guan, B.-O. Single-Molecule Ed. 2020, 59, 6428−6434.
Detection of Biomarker and Localized Cellular Photothermal Therapy (19) Li, P.; Chen, Q.; Wang, T. C.; Vermeulen, N. A.; Mehdi, B. L.;
Using an Optical Microfiber with Nanointerface. Sci. Adv. 2019, 5, Dohnalkova, A.; Browning, N. D.; Shen, D.; Anderson, R.; Gómez-
eaax4659. Gualdrón, D. A.; Cetin, F. M.; Jagiello, J.; Asiri, A. M.; Stoddart, J. F.;
(4) Biavardi, E.; Tudisco, C.; Maffei, F.; Motta, A.; Massera, C.; Farha, O. K. Hierarchically Engineered Mesoporous Metal-Organic
Condorelli, G. G.; Dalcanale, E. Exclusive Recognition of Sarcosine in Frameworks toward Cell-Free Immobilized Enzyme Systems. Chem.
Water and Urine by a Cavitand-Functionalized Silicon Surface. Proc. 2018, 4, 1022−1034.
Natl. Acad. Sci. U. S. A. 2012, 109, 2263−2268. (20) Chen, Y.; Li, P.; Modica, J. A.; Drout, R. J.; Farha, O. K. Acid-
(5) Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Resistant Mesoporous Metal-Organic Framework toward Oral Insulin
Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. Delivery: Protein Encapsulation, Protection, and Release. J. Am.
K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Chem. Soc. 2018, 140, 5678−5681.
Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; (21) Liang, J.; Gao, S.; Liu, J.; Zulkifli, M. Y. B.; Xu, J.; Scott, J.;
Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. Chen, V.; Shi, J.; Rawal, A.; Liang, K. Hierarchically Porous
M. Metabolomic Profiles Delineate Potential Role for Sarcosine in Biocatalytic MOF Microreactor as a Versatile Platform towards
Prostate Cancer Progression. Nature 2009, 457, 910−914. Enhanced Multienzyme and Cofactor-Dependent Biocatalysis. Angew.
(6) Henderson, C. J.; Pumford, E.; Seevaratnam, D. J.; Daly, R.; Hall, Chem., Int. Ed. 2021, 60, 5421−5428.
E. A. H. Gene to Diagnostic: Self Immobilizing Protein for Silica (22) Wang, X.; Lan, P. C.; Ma, S. Metal-Organic Frameworks for
Microparticle Biosensor, Modelled With Sarcosine Oxidase. Bio- Enzyme Immobilization: Beyond Host Matrix Materials. ACS Cent.
materials 2019, 193, 58−70. Sci. 2020, 6, 1497−1506.
(7) He, J.; Li, C.; Ding, L.; Huang, Y.; Yin, X.; Zhang, J.; Zhang, J.; (23) Liang, S.; Wu, X.-L.; Xiong, J.; Zong, M.-H.; Lou, W.-Y. Metal-
Yao, C.; Liang, M.; Pirraco, R. P.; Chen, J.; Lu, Q.; Baldridge, R.; Organic Frameworks as Novel Matrices for Efficient Enzyme
Zhang, Y.; Wu, M.; Reis, R. L.; Wang, Y. Tumor Targeting Strategies Immobilization: An Update Review. Coord. Chem. Rev. 2020, 406,
of Smart Fluorescent Nanoparticles and Their Applications in Cancer 213149.
Diagnosis and Treatment. Adv. Mater. 2019, 31, 1902409. (24) Huang, S.; Kou, X.; Shen, J.; Chen, G.; Ouyang, G. Armor-
(8) Yang, J.; Wang, Z.; Li, Y.; Zhuang, Q.; Gu, J. Real-Time
Plating” Enzymes with Metal-Organic Frameworks (MOFs). Angew.
Monitoring of Dissolved Oxygen with Inherent Oxygen-Sensitive
Chem., Int. Ed. 2020, 59, 8786−8798.
Centers in Metal-Organic Frameworks. Chem. Mater. 2016, 28,
(25) Hu, C.; Bai, Y.; Hou, M.; Wang, Y.; Wang, L.; Cao, X.; Chan,
2652−2658.
C.-W.; Sun, H.; Li, W.; Ge, J.; Ren, K. Defect-Induced Activity
(9) Xu, R.; Wang, Y.; Duan, X.; Lu, K.; Micheroni, D.; Hu, A.; Lin,
W. Nanoscale Metal-Organic Frameworks for Ratiometric Oxygen Enhancement of Enzyme-Encapsulated Metal-Organic Frameworks
Sensing in Live Cells. J. Am. Chem. Soc. 2016, 138, 2158−2161. Revealed in Microfluidic Gradient Mixing Synthesis. Sci. Adv. 2020, 6,
(10) Wang, S.; Chen, L.; Wahiduzzaman, M.; Tissot, A.; Zhou, L.; eaax5785.
Ibarra, I. A.; Gutiérrez-Alejandre, A.; Lee, J. S.; Chang, J.-S.; Liu, Z.; (26) Guo, J.; Yang, L.; Gao, Z.; Zhao, C.; Mei, Y.; Song, Y.-Y. Insight
Marrot, J.; Shepard, W.; Maurin, G.; Xu, Q.; Serre, C. A Mesoporous of MOF Environment-Dependent Enzyme Activity via MOFs-in-
Zirconium-Isophthalate Multifunctional Platform. Matter 2021, 4, Nanochannels Configuration. ACS Catal. 2020, 10, 5949−5958.
182−194. (27) Chen, S.-Y.; Lo, W.-S.; Huang, Y.-D.; Si, X.; Liao, F.-S.; Lin, S.-
(11) Wang, K. Y.; Feng, L.; Yan, T. H.; Qin, J. S.; Li, C. X.; Zhou, H. W.; Williams, B. P.; Sun, T.-Q.; Lin, H.-W.; An, Y.; Sun, T.; Ma, Y.;
C. Morphology Transcription in Hierarchical MOF-on-MOF Yang, H.-C.; Chou, L.-Y.; Shieh, F.-K.; Tsung, C.-K. Probing
Architectures. ACS Mater. Lett. 2021, 3, 738−743. Interactions between Metal-Organic Frameworks and Freestanding
(12) Li, J.-X.; Chang, G.-G.; Tian, G.; Pu, C.; Huang, K.-X.; Ke, S.- Enzymes in a Hollow Structure. Nano Lett. 2020, 20, 6630−6635.
C.; Janiak, C.; Yang, X.-Y. Near-Linear Controllable Synthesis of (28) Gkaniatsou, E.; Sicard, C.; Ricoux, R.; Benahmed, L.;
Mesoporosity in Hierarchical UiO-66 by Template-Free Nucleation- Bourdreux, F.; Zhang, Q.; Serre, C.; Mahy, J.; Steunou, N. Enzyme
Competition. Adv. Funct. Mater. 2021, 31, 2102868. Encapsulation in Mesoporous Metal-Organic Frameworks for
(13) Cirujano, F. G.; Martin, N.; Wee, L. H. Design of Hierarchical Selective Biodegradation of Harmful Dye Molecules. Angew. Chem.,
Architectures in Metal-Organic Frameworks for Catalysis and Int. Ed. 2018, 57, 16141−16146.
Adsorption. Chem. Mater. 2020, 32, 10268−10295. (29) Sun, Y.; Sun, L.; Feng, D.; Zhou, H.-C. An In Situ One-Pot
(14) Zhang, F.; Hu, X.; Roth, E. W.; Kim, Y.; Nguyen, S. T. Synthetic Approach towards Multivariate Zirconium MOFs. Angew.
Template-Assisted, Seed-Mediated Synthesis of Hierarchically Meso- Chem., Int. Ed. 2016, 55, 6471−6475.
15150 https://doi.org/10.1021/jacs.1c05674
J. Am. Chem. Soc. 2021, 143, 15145−15151
Journal of the American Chemical Society pubs.acs.org/JACS Article
15151 https://doi.org/10.1021/jacs.1c05674
J. Am. Chem. Soc. 2021, 143, 15145−15151